nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—urine—urinary bladder cancer	0.171	0.394	CbGeAlD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—S100A9—urinary bladder cancer	0.0985	0.174	CbGpPWpGaD
Ximelagatran—CYP2C9—urine—urinary bladder cancer	0.0681	0.157	CbGeAlD
Ximelagatran—F2—prostate gland—urinary bladder cancer	0.0614	0.141	CbGeAlD
Ximelagatran—F2—epithelium—urinary bladder cancer	0.0451	0.104	CbGeAlD
Ximelagatran—F2—renal system—urinary bladder cancer	0.0418	0.0963	CbGeAlD
Ximelagatran—F2—female reproductive system—urinary bladder cancer	0.0335	0.0771	CbGeAlD
Ximelagatran—F2—Regulation of IGF Activity by IGFBP—IGFBP3—urinary bladder cancer	0.0274	0.0484	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SLC19A1—urinary bladder cancer	0.0196	0.0346	CbGpPWpGaD
Ximelagatran—CYP2C9—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.0187	0.0331	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.0152	0.0268	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—urinary bladder cancer	0.0145	0.0256	CbGpPWpGaD
Ximelagatran—F2—PAR4-mediated thrombin signaling events—RHOA—urinary bladder cancer	0.0139	0.0246	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.0139	0.0245	CbGpPWpGaD
Ximelagatran—F2—Blood Clotting Cascade—PLAU—urinary bladder cancer	0.0137	0.0242	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.0134	0.0237	CbGpPWpGaD
Ximelagatran—CYP2C9—female reproductive system—urinary bladder cancer	0.0133	0.0307	CbGeAlD
Ximelagatran—F2—Regulation of IGF Activity by IGFBP—IGF1—urinary bladder cancer	0.0116	0.0205	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.0115	0.0202	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—MPO—urinary bladder cancer	0.0109	0.0193	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.00865	0.0153	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.00841	0.0149	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.00841	0.0149	CbGpPWpGaD
Ximelagatran—F2—Syndecan-4-mediated signaling events—RHOA—urinary bladder cancer	0.00757	0.0134	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—MMP9—urinary bladder cancer	0.00757	0.0134	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.0074	0.0131	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00727	0.0129	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00717	0.0127	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SOD2—urinary bladder cancer	0.00684	0.0121	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—GPX1—urinary bladder cancer	0.00653	0.0115	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—PLAU—urinary bladder cancer	0.00622	0.011	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—MTHFR—urinary bladder cancer	0.00602	0.0106	CbGpPWpGaD
Ximelagatran—F2—Syndecan-4-mediated signaling events—MMP9—urinary bladder cancer	0.00601	0.0106	CbGpPWpGaD
Ximelagatran—F2—PAR1-mediated thrombin signaling events—RHOA—urinary bladder cancer	0.00598	0.0106	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00589	0.0104	CbGpPWpGaD
Ximelagatran—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00587	0.0104	CbGpPWpGaD
Ximelagatran—F2—Thrombin signalling through proteinase activated receptors (PARs)—SRC—urinary bladder cancer	0.00555	0.0098	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.00543	0.00961	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.00518	0.00917	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—SRC—urinary bladder cancer	0.00494	0.00873	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.00478	0.00846	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.00447	0.00791	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—urinary bladder cancer	0.00419	0.00741	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTZ1—urinary bladder cancer	0.00401	0.00709	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00395	0.00699	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—NAT1—urinary bladder cancer	0.0038	0.00672	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTO2—urinary bladder cancer	0.0038	0.00672	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00375	0.00663	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL2—urinary bladder cancer	0.00356	0.0063	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—UGT2B7—urinary bladder cancer	0.00348	0.00615	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00343	0.00606	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—urinary bladder cancer	0.00324	0.00573	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.00319	0.00564	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.00313	0.00553	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00309	0.00546	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.00305	0.0054	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—FGFR3—urinary bladder cancer	0.00287	0.00508	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.0027	0.00477	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CDX2—urinary bladder cancer	0.00269	0.00476	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00265	0.00468	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—urinary bladder cancer	0.00259	0.00459	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—urinary bladder cancer	0.00229	0.00404	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—SRC—urinary bladder cancer	0.00225	0.00397	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—RHOA—urinary bladder cancer	0.00221	0.00391	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.00208	0.00368	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—urinary bladder cancer	0.00206	0.00364	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00205	0.00363	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—KRAS—urinary bladder cancer	0.00186	0.00329	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.00176	0.00312	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.00169	0.00299	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.00167	0.00294	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.00161	0.00286	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	0.00161	0.00285	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCL8—urinary bladder cancer	0.0016	0.00283	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—HRAS—urinary bladder cancer	0.00158	0.0028	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IFNA2—urinary bladder cancer	0.00157	0.00278	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.00156	0.00275	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—EGFR—urinary bladder cancer	0.00142	0.00251	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	0.00135	0.00239	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—KRAS—urinary bladder cancer	0.00134	0.00237	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HDAC4—urinary bladder cancer	0.00121	0.00214	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.0012	0.00213	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	0.00118	0.00209	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.00112	0.00198	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLAU—urinary bladder cancer	0.00112	0.00197	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.0011	0.00195	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.00107	0.0019	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	0.00106	0.00187	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.00103	0.00182	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00101	0.00179	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GLI1—urinary bladder cancer	0.00101	0.00179	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	0.001	0.00177	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CREBBP—urinary bladder cancer	0.00092	0.00163	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IGF1—urinary bladder cancer	0.000908	0.00161	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	0.00085	0.0015	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—RHOA—urinary bladder cancer	0.000832	0.00147	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000817	0.00144	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF1—urinary bladder cancer	0.000715	0.00126	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2—urinary bladder cancer	0.000698	0.00123	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RBX1—urinary bladder cancer	0.000695	0.00123	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	0.000686	0.00121	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TSC1—urinary bladder cancer	0.000653	0.00116	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	0.00065	0.00115	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NAT1—urinary bladder cancer	0.00065	0.00115	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000639	0.00113	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—EP300—urinary bladder cancer	0.000626	0.00111	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JAG1—urinary bladder cancer	0.000622	0.0011	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SRC—urinary bladder cancer	0.000609	0.00108	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	0.000595	0.00105	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CXCL8—urinary bladder cancer	0.000575	0.00102	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	0.000535	0.000946	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000526	0.00093	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	0.000506	0.000894	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KRAS—urinary bladder cancer	0.000504	0.000892	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—S100B—urinary bladder cancer	0.000504	0.000891	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	0.000493	0.000871	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—RHOA—urinary bladder cancer	0.000478	0.000844	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000462	0.000816	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NCOR1—urinary bladder cancer	0.000453	0.000801	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—urinary bladder cancer	0.000448	0.000793	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2—urinary bladder cancer	0.000441	0.00078	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—HRAS—urinary bladder cancer	0.000429	0.000758	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000419	0.000741	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2—urinary bladder cancer	0.000401	0.000708	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TERT—urinary bladder cancer	0.000399	0.000706	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000395	0.000698	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TYMP—urinary bladder cancer	0.000394	0.000696	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000378	0.000669	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGFR3—urinary bladder cancer	0.000366	0.000648	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NAT2—urinary bladder cancer	0.000356	0.00063	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ESR1—urinary bladder cancer	0.000356	0.000629	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CREBBP—urinary bladder cancer	0.000312	0.000551	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1—urinary bladder cancer	0.000308	0.000544	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—RRM2—urinary bladder cancer	0.000307	0.000544	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EGFR—urinary bladder cancer	0.000306	0.000542	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KRAS—urinary bladder cancer	0.000289	0.000512	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	0.000285	0.000503	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ENO2—urinary bladder cancer	0.000285	0.000503	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000283	0.0005	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RHOA—urinary bladder cancer	0.000282	0.000499	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	0.000276	0.000488	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000272	0.000481	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB2—urinary bladder cancer	0.000261	0.000462	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL8—urinary bladder cancer	0.000248	0.000438	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HRAS—urinary bladder cancer	0.000246	0.000435	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2—urinary bladder cancer	0.000237	0.000418	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCND1—urinary bladder cancer	0.000231	0.000408	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NQO1—urinary bladder cancer	0.00023	0.000406	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—urinary bladder cancer	0.000224	0.000396	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000223	0.000395	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000223	0.000394	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTEN—urinary bladder cancer	0.000223	0.000394	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EP300—urinary bladder cancer	0.000212	0.000375	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SRC—urinary bladder cancer	0.000207	0.000365	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000194	0.000343	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	0.000191	0.000338	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000185	0.000327	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MYC—urinary bladder cancer	0.000185	0.000327	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGFR—urinary bladder cancer	0.000181	0.00032	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TYMS—urinary bladder cancer	0.000178	0.000315	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	0.000176	0.000311	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	0.000176	0.000311	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KRAS—urinary bladder cancer	0.000171	0.000302	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPX1—urinary bladder cancer	0.000168	0.000298	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	0.000165	0.000292	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	0.000155	0.000275	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—urinary bladder cancer	0.000152	0.000269	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HRAS—urinary bladder cancer	0.000145	0.000257	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARG—urinary bladder cancer	0.000126	0.000223	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	0.000121	0.000214	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	9.92e-05	0.000175	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTEN—urinary bladder cancer	8.65e-05	0.000153	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—EP300—urinary bladder cancer	8.25e-05	0.000146	CbGpPWpGaD
